Literature DB >> 16987041

Thioredoxin-1 suppresses systemic inflammatory responses against cigarette smoking.

Atsuyasu Sato1, Tomijiro Hara, Hajime Nakamura, Noriko Kato, Yuma Hoshino, Norihiko Kondo, Michiaki Mishima, Junji Yodoi.   

Abstract

Thioredoxin-1 (TRX) is a small redox-active protein with antioxidative effects and redox-regulating functions. Cigarette smoking is a major etiological factor in the pathogenesis of a variety of diseases and recruits systemic immune and inflammatory responses. This report demonstrates that TRX attenuates the systemic inflammatory responses induced by cigarette smoking. The mRNA expressions of tumor necrosis factor alpha (TNF-alpha) and macrophage migration inhibitory factor (MIF) were suppressed in the spleen of TRX overexpressing transgenic mice (TRX-tg) exposed to cigarette smoking, compared with control C57BL/6 mice. In addition, protein carbonylation, a marker of cellular protein oxidation, was enhanced by cigarette smoking in the tissues of heart and liver in control mice more than in TRX-tg mice. These findings suggest that TRX may suppress the systemic inflammatory responses against cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987041     DOI: 10.1089/ars.2006.8.1891

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  11 in total

1.  Thioredoxin-related mechanisms in hyperoxic lung injury in mice.

Authors:  Trent E Tipple; Stephen E Welty; Lynette K Rogers; Thomas N Hansen; Young-Eun Choi; James P Kehrer; Charles V Smith
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

Review 2.  Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor.

Authors:  Susannah K Leaver; Niall S MacCallum; Vasisht Pingle; Matthew B Hacking; Gregory J Quinlan; Timothy W Evans; Anne Burke-Gaffney
Journal:  Intensive Care Med       Date:  2009-09-15       Impact factor: 17.440

Review 3.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

Review 4.  Antioxidant therapeutic advances in COPD.

Authors:  Irfan Rahman
Journal:  Ther Adv Respir Dis       Date:  2008-12       Impact factor: 4.031

Review 5.  Thioredoxin/Txnip: redoxisome, as a redox switch for the pathogenesis of diseases.

Authors:  Eiji Yoshihara; So Masaki; Yoshiyuki Matsuo; Zhe Chen; Hai Tian; Junji Yodoi
Journal:  Front Immunol       Date:  2014-01-09       Impact factor: 7.561

6.  Lycopene Ameliorates Liver Inflammation and Redox Status in Mice Exposed to Long-Term Cigarette Smoke.

Authors:  Daniela Fonseca Abdo Rocha; Pedro Alves Machado-Junior; Ana Beatriz Farias Souza; Thalles de Freitas Castro; Guilherme de Paula Costa; André Talvani; Frank Silva Bezerra; Silvia Dantas Cangussú
Journal:  Biomed Res Int       Date:  2021-11-25       Impact factor: 3.411

7.  Thioredoxin-1 protects against neutrophilic inflammation and emphysema progression in a mouse model of chronic obstructive pulmonary disease exacerbation.

Authors:  Naoya Tanabe; Yuma Hoshino; Satoshi Marumo; Hirofumi Kiyokawa; Susumu Sato; Daisuke Kinose; Kazuko Uno; Shigeo Muro; Toyohiro Hirai; Junji Yodoi; Michiaki Mishima
Journal:  PLoS One       Date:  2013-11-11       Impact factor: 3.240

8.  Sulforaphane enhances the ability of human retinal pigment epithelial cell against oxidative stress, and its effect on gene expression profile evaluated by microarray analysis.

Authors:  Liang Ye; Ting Yu; Yanqun Li; Bingni Chen; Jinshun Zhang; Zhongyang Wen; Bo Zhang; Xiaohong Zhou; Xiaoqing Li; Feng Li; Wei Cao; Zhong Huang
Journal:  Oxid Med Cell Longev       Date:  2013-09-25       Impact factor: 6.543

9.  Cigarette smoke reversibly activates hypoxia-inducible factor 1 in a reactive oxygen species-dependent manner.

Authors:  Hiroki Daijo; Yuma Hoshino; Shinichi Kai; Kengo Suzuki; Kenichiro Nishi; Yoshiyuki Matsuo; Hiroshi Harada; Kiichi Hirota
Journal:  Sci Rep       Date:  2016-09-29       Impact factor: 4.379

Review 10.  Progress in the mechanism and targeted drug therapy for COPD.

Authors:  Cuixue Wang; Jiedong Zhou; Jinquan Wang; Shujing Li; Atsushi Fukunaga; Junji Yodoi; Hai Tian
Journal:  Signal Transduct Target Ther       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.